STAT March 8, 2021
Helen Branswell

Though nearly 300 million doses of Covid-19 vaccines have been administered around the globe so far, the world still has a long way to go before we can think about declaring the pandemic over.

Vaccine distribution remains wildly inequitable, with wealthy countries vaccinating at far higher rates than low- and middle-income countries.

Meantime, with the scramble to ramp up manufacturing, there are concerns that the production of Covid-19 vaccines could cannibalize the ability of companies to make and distribute other vaccines, like those that protect against dangerous pathogens like rabies, tetanus, measles, and human papillomavirus.

CEPI, the Coalition for Epidemic Preparedness Innovations, is among the organizations thinking critically about these issues. It’s also one of the partners — along with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Supply Chain, Technology
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
Navigating COVID: a journey from academic intensity to healing
Covid-19 Vaccination Associated With Reductions In Pediatric Cases & Hospitalizations
Are We Testing Enough for H5N1?

Share This Article